The Cancer Letter

Inside information on cancer research and drug development

In Brief

Vacirca elected COA president

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Jeffrey Vacirca was elected president of the Community Oncology Alliance for a one year term starting Jan. 1.

Vacirca is the CEO and managing partner/director of clinical research at New York Cancer Specialists in Long Island, NY.

In addition to Vacirca, new executive committee officers and members of the board of directors were elected.

A complete and updated list of Officers and Board members can be viewed here.

Table of Contents

YOU MAY BE INTERESTED IN

Conversation with The Cancer Letter

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.
By Matthew Bin Han Ong
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account